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Abstract. This essay proposes a new approach to risk evaluation using disease 
mathematical modeling. The mathematical model is an algebraic equation of the 
available database attributes and is used to evaluate the patient condition. If its 
value is greater than zero it means that the patient is ill (or in risk condition), 
otherwise healthy. In practice risk evaluation has been a very difficult problem 
mainly due its sporadic behavior (suddenly, the patient has a stroke, etc as a 
condition aggravation) and its database representation. The database contains, 
under the label of risk patient data, information of the patient condition that 
sometimes is in risk condition and sometimes is not, introducing errors in the 
algorithm training. The study was applied to Atherosclerosis database from 
Discovery Challenge 2003 - ECML/PKDD 2003 workshop. 
Objectives 
 
This essay addresses the problem of obtain a mathematical model able to 
discriminate risk patients and forecast acute conditions. The mathematical model is a 
function of the available attributes of the database and uses the predefined 
classification of risky patients (NORMAL or RISK / PATHOLOGICAL).  
The main bottleneck of risk evaluation is that the patient sometimes is in a risky 
condition and sometimes is not, and all database records are labeled as risk condition.  
Our main objective is to obtain the discriminate function able to evaluate the risk 
condition where sometimes a risky patient is in normal condition (where there is no 
indication of any risk). To obtain the discriminate function, we use genetic 
programming, an artificial intelligence approach which output is a mathematical 
model of the predefined operators and database attributes. 
We apply for the workshop to discuss how to extract knowledge from our model. 
The comparison of our results with other different approaches and expert 
presentations during the conference will allow us to understand it better, and develop 
effective methods of knowledge extraction and representation. 
A detailed discussion about many diagnostic methods, the comparison with 
discriminate function and its results for breast cancer and collagen disease is available 
in Werner and Kalganova [1] and Werner and Fogarty [2],[3]. 
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The methodology 
 
Our approach differs from all previous approaches because it generates a 
mathematical algebraic model (discriminate function) used to classify the patient data. 
We define the operators (such as summation, subtraction, multiplication, etc) that 
should be used in the model assembly. Any type of model can be obtained by Genetic 
Programming (GP). 
Discriminate function maps the original multi dimensional space in a one-
dimensional real number image. The output space has a threshold with separate 
diagnostic classes. In this essay the origin was adopted as a threshold: positive values 
mean a risky patient and negative values a normal patient. 
Fig. 1 shows the methodology to obtain the discriminate function. The available 
information from the database is used to test each different model, and the number of 
correct prediction is used to evaluate the quality of each model trial. 
The discriminate function can be used to evaluate new patient data, classifying his 
condition because it contains the disease dynamics. It means that understanding the 
model we will be able to understand the disease mechanism, and develop new 
treatments. The time behavior of the discriminate function values helps to forecast 
possible crisis. 
 
 
Fig. 1. Original database attributes are used by genetic programming to obtain an algebraic 
equation which contains the disease dynamics. 
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Genetic Programming 
GP is an optimization algorithm which mimics the evolution and improvement of 
life through reproduction. Individual in the population represents a different algebraic 
equation (discriminate function). Each individual contributes with its own genetic 
information to the building of new ones (offspring) adapted to the environment with 
higher chances of surviving. This is the basis of genetic algorithms and programming 
[4], [5], [6], and [7].  
Fig 2 shows the algorithms stages. The first stage consists in the generation of 
random models for each individual of the population and model accuracy is evaluated. 
The evaluation process measure the performance of each model in the 
classification of the data available in the database. This performance (termed fitness 
function) is used to select the parents that contribute with their chromosomes. 
Genetics operators include mutation (the change of a randomly chosen bit in the 
chromosome) and crossover (the exchange of randomly chosen slices between two 
chromosomes). 
The best individuals are continuously being selected, and crossover and mutation 
take place. Following a number of generations, the population converges to the 
solution that performs the best, e.g., the best model that represent the disease and is 
able to classify the patient risk. 
The software we have developed is an adaptation of LilGP [8], where GP is 
structured in a pre-compiled library. Outputs are written in Excel XLS format direct 
from the program, to generate an accessible and functional Human-Computer 
Interface (HCI).  
 
 
Fig. 2. Genetic programming stages 
 
Chromosome representation. The chromosome represents the model of the 
problem solution using trees. A tree is a model representation that contains nodes and 
leaves.  
Nodes are mathematical operators. We have used multiplication, addition, 
subtraction, and division. Leaves are terminals (the attributes of the dataset and 
numbers). The discriminate function in a GP context is a tree using operators (or so 
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called Functions) and leaves (or so called Terminals).  Let us consider the following 
discriminate function:  
 
X1+3.14 · X2+5.3 / X3 
 
In the tree representation it can be rewritten as following: 
 
(+ X1 (+ (· 3.14  X2) (/ 5.3  X3))) 
 
where X1, X2, and X3 are the attributes of the clinical data, and multiplication(·), 
addition(+), subtraction (-), and division(/) are the operators. Replacing the values of 
the clinical data in the equation results in a number which should be positive (the 
patient is ill) or negative (the patient is healthy). 
Genetic operators . Trees are manipulated through genetic operators. The 
crossover operator points a tree branch and exchanges it with another branch and 
obtains new trees. The mutation operator changes the branch for a random new 
branch. The length of the chromosome is variable.  
The probability of crossover is 60% and the probability of mutation is 20%. We 
adopt a high value of the mutation probability to spread the population over all 
solution space. 
Fitness function. Fitness function defines the quality of chromosome as a solution 
to the problem. It is a numerical positive value. The dataset is used to obtain the 
model that maximizes the fitness function. 
The fitness function F used in the disease diagnostic is the accuracy of the model: 
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where Nok is the number of correct forecast and Nnot is the number of false forecasts. 
To analyze the knowledge represented in the discriminate function, the separation 
between positive and negative cases and the influence of each variable, we introduced 
a plot of the partial derivative with respect to a variable by the difference in the 
discriminate function if this variable is set to zero. Each axis of the function is defined 
as: 
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(2) 
where 2·d is the step of the numerical derivative in axis X; x,y,… are attributes of the 
dataset and z is the discriminate function. On the Y axis, the value of the attribute less 
itself set to null is used to evaluate its effects in the total value of the discriminate 
function.   
The X axis shows the behavior of the patient, if he is better (negative values) or 
worse (positive values). The Y axis shows the contribution of the variable to the 
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improvement of the patient condition (negative value) or to aggravate their condition 
(positive values). The ideal conditions are both negative values, and the sickly 
conditions are both positive values.  
We termed this graphic as Disease Pathway Graphic - DPG, because it reproduces 
the pathway the patients follow during their recovery in the plane defined by the 
transformation in Eq. 2. 
Data mining effort in atherosclerosis dataset [9]. 
The use of the attribute in algebraic equations demands a continuous and coherent 
definition of its values. Continuous variables like cholesterol in mg% present a clear 
meaning: bigger the module, bigger the concentration of cholesterol. 
However, discrete values like married, divorced, single, widower must be sorted in 
a sequence that shows the stress or constraint like married, divorced, widower, and 
single. The responsibility, stability, or stress in some criteria should be monotone 
increasing/decreasing values. 
Values not stated were set to zero, because in this case it does not changes the 
discriminate function value. 
The final dataset was obtained combining the record from “Entry” file as the first 
sequence of measures for each patient, and the posterior records from “Control” 
executes some change in the last value of the patient record, generating a new record 
in the database. The final dataset contains 11989 records, each one representing a 
different sample. 
To avoid bias, all attributes were normalized between 0.01 and 1.0 and genetic 
programming uses this database to obtain the discriminate function. 
Experimental results 
The discriminate function was able to model 8426 records correctly (71%) and 
3563 records wrong (29%). The model obtained is: 
 
(+ (+ (+ (+ (- (- (- alcohol vzdelani) (- (* (* (+ moc chlst) (+ kysmoc (+ (+ (* (- 
dusnost pivo12) (- alcohol kysmoc)) (- syst1 (- hypll HTD))) (* ldl glykemie)))) (+ (* 
-3.33355 (* glykemie HT)) (+ (+ (+ (+ imtrv (* -3.33355 (* glykemie HT))) (+ (* 
glykemie HT) (+ (+ (- hypll HTD) (* ldl glykemie)) (* ldl glykemie)))) (- alcohol 
vzdelani)) (+ (* ldl glykemie) glykemie)))) (+ (+ (- ICT vinomn) (+ (+ (- (* -3.33355 
byvkurak) HT) (* -3.33355 (* glykemie HT))) hypll)) (* (- vyska HTD) (+ dusnost 
alcohol))))) HT) (* -3.33355 (* glykemie HT))) dobakour) (+ (* (+ imtrv (* -3.33355 
(* glykemie HT))) byvkurak) syst2)) (+ (+ (+ vzdelani (+ (* vinomn byvkurak) 
smoking)) (* (- dusnost pivo12) (- dusnost pivo12))) (+ (+ (+ glykemie (* glykemie 
HT)) (- hypll HTD)) (* ldl glykemie)))) 
 
See Table III for description of mnemonics in the model. 
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Analysis of accuracy. The result obtained (71%) shows a lower accuracy than the 
one obtained in breast cancer (96%). To understand its meaning, let us define an 
average “normal” patient obtained from the dataset of “normal studied group” 
patients: body mass index (23.28), blood pressure ( syst 129 diast 82), cholesterol 
(216), and triglycerides (147). 
Consider the patient 10001 from the risk group. The discriminate function fail to 
obtain his risk condition (see *** in column OK/NOK Table I) when he has the 
physical and biochemical parameters stable. 
Fig 3 shows the evolution of the discriminate function and its tendencies. It is 
evident the discriminate function changes its value depending on the patient clinical 
condition. The doctor should take some action when measured the sample 13 (an 
increasing tendency since sample 9) to prevent the increase in samples 14, 15, etc. 
This is a very important point, because the analysis of discriminate function 
temporal behavior can forecast future problems of the patient.  
 
Fig. 3. Evolution of discriminate function over the analysis. The axis represents the 
discriminate function by sample number (# in Table I). 
To study the discrepancies, let us define an index of risk. Each of Table I attributes 
has an average value for normal patients and let us define a discrepancy threshold if 
its value is bigger than 10% of the average value. The index is the squared sum of the 
all discrepancies bigger than 10%.  
Table I shows that the discriminate function fails to show risk conditions when the 
discrepancy is close or bellow the threshold. This means that the discriminate function 
is not affected by the indistinct classification of data as risk when it is not. 
Applying this study for all records where the discriminate function missed (total 
3563 cases) is shown in Table II. The discriminate function classify a risk patient with 
discrepant attributes when the patient is normal and the discrepancy is greater than 0 
(total 451 cases), or in the other cases when discrepancy is less than 0 (total 2443 
cases ).    
 
Decrease 
Tendency 
Increase 
Tendency 
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Table 1. Analysis of physical and biochemical parameters for patient 10001 
# VYSKA VAHA SYST1 DIAST1 CHLST TRIGL 
OK 
NOK Index 
0 169 71 120 85 209 86   0.00 
1 169 71 130 90 217 108 *** 0.00 
2 169 72 140 90 232 389   1.65 
3 169 71 130 90 241 134 *** 0.12 
4 169 74 150 100 201 126   0.30 
5 169 73 165 105 235 88   0.40 
6 169 71 130 92 216 76   0.12 
7 169 72 175 105 205 74   0.45 
8 169 74 140 95 286 71   0.38 
9 169 75 130 90 189 86 *** 0.13 
10 169 74 130 90 216 70 *** 0.11 
11 169 68 140 90 170 89 *** 0.00 
12 169 71 140 90 193 75 *** 0.00 
13 169 72 140 90 215 83 *** 0.00 
14 169 71 120 85 219 87   0.00 
15 169 70 160 100 232 60   0.33 
16 169 71 140 90 178 89   0.00 
17 169 72 150 85 215 84   0.16 
18 169 72 180 100 170 69   0.45 
 
Table II. Analysis of discrepancy. 
Patient type Discrepancy >0 Discrepancy<0 TOTAL 
Normal 451 102 553 
Risk 426 2423 2879 
Pathologic 107 17 125 
Death 3 3 6 
  
Hence, the method found correct values in 8426 cases when running GP to obtain 
the discriminate function, and is correct in 451+2443 cases where the discriminate 
value do not gave the classification due the condition of the patient do not agree with 
his classification. The total of correct values (8426+451+2443=11320) represents 
94% of the total number of records (11989). 
The selection of all individuals where the discriminate transited between 
positive/negative values are 202 and 269 for decrease and increase tendency. The 
study of the behavioral attributes to establish the causes of this change is available in 
Table III. 
First of all, the transition probability in both directions is the same. This is an 
important point of discussion for the workshop.  
There are several behaviors that can help in the transition: be married, high 
education, partly independent, mainly sits in the job (???), moderate physical activity 
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after job, drink only occasionally, do not smoke, sugar not affect, less than 2 glasses 
of coffee a day, and less than 2 glasses of tea a day.     
 
Table III Attributes influence in discriminate transition 
Attribute %Dec %Incr Attribute %Decr %Incr 
Married 87 89 basic  0 0 
Divorced 1 2 apprentice 15 16 
Widower 1 1 Secondary 38 35 
STAV- 
married 
status  
 Single 9 7 
VZDELAN
I- reached 
education 
 University 46 48 
Manageria
l 
21 19 mainly sits 70 67 
partly 
independe
nt 
39 31 mainly 
stands  
10 13 
Others 27 24 mainly 
walks 
15 15 
ZODPOV-
responsibil
ity in a job 
 
Pensioner 11 24 
TELAKTZ
A-physical 
activity in 
a job 
 
heavy 
loads 
3 3 
mainly sits 18 17 No 10 10 
Moderate 68 73 Occasiona
lly 
69 66 
AKTPOZA
M- 
physical 
activity 
after a job 
 
Great 12 9 
ALKOHOL 
- drinking 
of alcohol 
 Regularly 20 23 
No 64 65 No 20 21 
1-4 5 4 1-3 23 24 
5-14 10 6 4-6 31 34 
15-20 14 11 
>21 5 10 
KOURENI 
- intensity 
of smoking 
 
Cigars/pip
es 
0.5 2 
CUKR -  
daily 
consumpti
on 
of sugar 
lumps 
7-9 12 12 
No 27 32 No 40 36 
1-2 51 46 1-2 52 55 
KAVA -
daily 
consumpti
on of 
coffee 
 
>3 22 21 
CAJ - daily 
consumpti
on of tea >3 7 8 
 
 Analysis of the influence of each attribute in the discriminate 
function. 
Table IV shows the DPG of each relevant attribute in the discriminate function 
value for the correct predictions of the GP run. 
The analysis of the Table IV shows that discriminate function cluster the data, in 
two different groups (risk and not risk). The supervision of the DPG patient pathway 
would contribute to forecast the evolution of patient conditions. 
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Table IV DPG for main attributes of discriminate function 
Attribute Health Patient Risk Patient 
VZDELANI - 
reached 
education 
ZODPOV - 
responsibilit
y in a job 
TELAKTZA  - 
physical 
activity in a 
job 
ALKOHOL - 
drinking of 
alcohol 
PIVO12 - 
beer 12° 
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HT - 
hypertensio
n 
HTD - diet 
in HT 
IMTRV – 
before how 
many years 
myocardial 
infarction 
has 
appeared 
DUSNOS
T - asthma 
VAHA - 
weight (kg) 
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SYST1  - 
blood 
pressure I 
systolic (mm 
Hg) 
  
CHLST - 
cholesterol 
in mg% 
 
MOC - 
urine 
 
Summary and conclusions  
 
This essay studies how to obtain the mathematical model of the disease, and 
classify the patient condition. The method is able to deal with the problem of patient 
label (risk even when the condition is not risk). 
The accuracy of the method is around 94%, if considered the 10% average 
deviation index to classify the patient condition. 
The forecast of the patient condition can be done by the discriminate function 
monitoring and analysis of its tendency.  This is a procedure easy to be executed in 
any laboratory. 
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Topics for discussion during the workshop. 
The discriminate function is able to classify patients with different level of risk 
with good accuracy. We would appreciate very much discuss what information is able 
to be obtained from the DPG and how to analyze it, based in the information obtained 
by others data mining techniques. 
Other important question is why the decrease and increase tendency presents the 
same number of events for the same conditions? I guess that there are different causes 
for increase and decrease. 
Discriminate function is a powerful tool, and the interpretation of its results would 
contribute in the understanding of many diseases where the method was applied. 
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